h1

h2

h3

h4

h5
h6
% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@PHDTHESIS{Rimal:983712,
      author       = {Rimal, Rahul},
      othercontributors = {Möller, Martin and Ludwig, Andreas},
      title        = {{S}caffold-free models for tissue engineering},
      school       = {RWTH Aachen University},
      type         = {Dissertation},
      address      = {Aachen},
      publisher    = {RWTH Aachen University},
      reportid     = {RWTH-2024-03644},
      pages        = {1 Online-Ressource : Illustrationen},
      year         = {2024},
      note         = {Veröffentlicht auf dem Publikationsserver der RWTH Aachen
                      University; Dissertation, RWTH Aachen University, 2024},
      abstract     = {The advancement of tissue engineering techniques has
                      provided an alternate strategy for accessing and predicting
                      the efficacy of novel pharmaceuticals and cosmetics. The
                      urgent need for three-dimensional (3D) organotypic models
                      stems from the limitations of the conventional testing
                      platforms, including two-dimensional (2D) cell monolayers
                      that fail to replicate the intricate architecture of the
                      human tissue and animal models that raise ethical concerns.
                      To compete with these existing pre-clinical platforms,
                      organotypic 3D models need to exhibit longevity and
                      stability. However, most in-vitro studies are conducted for
                      short durations, thereby impeding the understanding of
                      disease progression, long-term influence of the administered
                      drugs/cosmetics, and the consequences of treatment
                      discontinuation. In this thesis, to fabricate 3D human skin
                      tissue models, we employed ECM cell-coating and accumulation
                      technique where individual dermal fibroblast was coated
                      layer-by-layer with fibronectin (FN) and gelatin (G). The
                      coated cells, once accumulated in a confined space, interact
                      with each other to form a scaffold-free 3D tissue. Human
                      keratinocytes were seeded on top of the formed dermis and
                      the models were subsequently cultured in air-liquid
                      interface (ALI) to mimic native skin architecture. The
                      scaffold-free skin models showed long-term durability (49
                      days) where the epidermal compartment sustained its
                      differentiated phenotype without infiltration of
                      keratinocytes into the dermal compartment. Given this
                      robustness, the skin models were utilized to simulate
                      psoriasis, an incurable, immune-mediated inflammatory
                      disease and a clinically approved drug was tested on the
                      skin models. To induce a psoriasis-like phenotype, the skin
                      models were stimulated with recombinant human interleukin
                      17A (rhIL-17A). Following stimulation, the skin models were
                      systemically treated with the anti-IL-17A antibody
                      Secukinumab in the presence of rhIL-17A. Microarray and
                      RT-PCR analysis revealed that skin models treated with
                      rhIL-17A showed downregulation of differentiation markers
                      and upregulation of chemokines and cytokines, while
                      treatment with anti-IL-17A antibody reversed these gene
                      regulations. These findings demonstrated, at the molecular
                      level, the effects of anti-IL-17A antibody on
                      rhIL-17A-induced gene regulations, highlighting the
                      physiological relevance of the developed skin model as an
                      alternative to animal experiments. Therefore, the entire
                      course of the disease, from the onset of the disease
                      phenotype to the drug administration and the subsequent drug
                      efficacy, was recapitulated in-vitro. Similarly, in another
                      study, long-term models of atopic dermatitis were
                      established by exposing the skin models to Interleukin 4
                      (IL-4) and Interleukin 13 (IL-13). Atopic dermatitis is a
                      common skin disease characterized by immune infiltration and
                      activation, resulting in inflammation, vascular changes, and
                      disruption of the skin barrier. Upon successful fabrication
                      of the dermatitis models, a standard topical spheroid was
                      applied and the histological changes were observed on the
                      scaffold-free disease models. Another approach to enhance
                      the longevity of laboratory-cultured tissues involves
                      providing nutrients to the tissue through a network of blood
                      vessels (BV). Vascularization is a prevailing challenge in
                      the field of tissue engineering. Although vascularization is
                      known to improve the longevity of skin models by
                      transporting nutrients, growth factors and oxygen, BV in
                      in-long-term vitro models tend to be inherently unstable.
                      The interplay of different cell types in within the models
                      leads to alterations in the vascular system, which can be
                      detrimental for the long-term stability of the functional
                      BV. Skin models consists of human fibroblasts and
                      keratinocytes that uniquely stimulate the BV. In ECM-coated
                      scaffold-free models, the addition of keratinocytes led to
                      uncontrolled angiogenesis and the formation of abnormal BV.
                      Enhanced vascular growth factor (VEGF) and proteinases
                      activity was observed after the addition of keratinocytes.
                      To prevent this instability, the skin models were cultured
                      within a 3D-printed bioreactor that provided continuous
                      media perfusion to the vascularized skin tissues. Dynamic
                      flow culture restored tissue homeostasis by balancing the
                      expression of proteinase and their inhibitors, and
                      regulating angiogenesis. This led to improvements in skin
                      barrier properties, facilitated the fabrication of thicker
                      tissues, and enhanced wound closure. Furthermore, the
                      vascularized skin in flow culture promoted vascular openings
                      as perfusable sites. In summary, the use of scaffold-free
                      models and the bioreactor enabled the cultivation of the
                      vascularized models with intact BV for a duration of
                      28-day.ECM-coated scaffold-free methods were also utilized
                      to form vascularized breast cancer models where the
                      ECM-coated fibroblasts were mixed together with endothelial
                      cells and cancer cells. Specifically, triple-negative breast
                      cancer cells (MDA-MB231) were utilized to create the
                      vascularized tumor model. The breast cancer cells exhibited
                      highly elongated morphology within the in-vitro tissue
                      compared to the 2D culture. Within the 3D microenvironment,
                      breast cancer cells led to vascular abnormality, a hallmark
                      of cancer. Furthermore, the breast cancer models were
                      co-cultured with osteoblasts (bone-forming cells) to
                      understand the paracrine effect of osteoblasts on the
                      cancerous tissue, thereby constituting a complex
                      four-cellular tumor progression model. Co-culture with
                      osteoblasts in the presence of cancer cells, led to
                      increased BV tortuosity and impairment. Overall, this
                      doctoral thesis focuses on the utilization of human 3D
                      scaffold-free models to replicate various pathologies,
                      ranging from skin diseases to cancer. These models
                      demonstrate a long-term stability in culture, enabling
                      extended drug treatment and analysis. Furthermore, the
                      thesis investigates the alterations in vasculature in static
                      culture condition and emphasizes on the necessity of dynamic
                      flow culture conditions.},
      cin          = {154610 / 150000 / 052200},
      ddc          = {540},
      cid          = {$I:(DE-82)154610_20140620$ / $I:(DE-82)150000_20140620$ /
                      $I:(DE-82)052200_20140620$},
      typ          = {PUB:(DE-HGF)11},
      doi          = {10.18154/RWTH-2024-03644},
      url          = {https://publications.rwth-aachen.de/record/983712},
}